The GMP certificate will allow the manufacturing site in Hervás, Cáceres to manufacture active ingredients for the pharmaceutical industry that is based on medicinal plants
SIBUR is developing a special grade of polycarbonate compatible with radiation sterilization
To set a new standard in oncology, offering highly targeted radiation therapy that improves treatment precision, and accelerates recovery for cancer patients
Target identification will commence on 17 September 2024, following the timeline provided in the campaign guidelines
The new facility further improves the operational efficiency and readies the site for the completion of the new large-scale production plant
Critical resources will help Genvor to grow and scale biological crop protection products and innovative trait technologies
Stringent regulatory environments can make OEMs reluctant to change processes and materials for approved medical devices
The company recorded sales of Rs. 1,129 crore for the fiscal year ended June 30, 2024,
Gross profit was Rs. 328.8 crore, up by 27.8% YoY with a gross margin expansion of 418 bps to 55.7%
Subscribe To Our Newsletter & Stay Updated